SEC Form 4 · accession 0001192482-17-000212
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alison B Fleming
Officer — Chief Technology Officer
Period of report
Aug 4, 2017
Accepted (ET)
Aug 4, 2017 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2017 | A | 639 | $10.60 | A | 24,952 | D | |
| Common StockF2 | Aug 4, 2017 | F | 200 | $12.39 | D | 24,752 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.